Trial Profile
A Phase 1/2 Study of ADR-001 in Patients With Liver Cirrhosis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Jul 2023
Price :
$35
*
At a glance
- Drugs ADR-001 (Primary)
- Indications Liver cirrhosis
- Focus Adverse reactions; First in man; Therapeutic Use
- Sponsors Rohto Pharmaceutical
- 04 Jul 2023 Status changed from recruiting to completed.
- 24 Oct 2022 Planned End Date changed from 1 Dec 2022 to 1 Sep 2023.
- 24 Oct 2022 Planned primary completion date changed from 1 Jun 2022 to 1 Jul 2023.